2027 ICD-10-CM Diagnosis Code L75.2Apocrine miliaria
ICD-10-CM Codes›L00–L99›L60-L75›L75
- Billable — Valid for Submission
- Chronic Condition
L75.2 is a billable ICD-10-CM diagnosis code for apocrine miliaria. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 606 through 607. Coders also document this condition as apocrine duct occlusion disorder. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified skin disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Apocrine duct occlusion disorder
- Apocrine miliaria
- Apocrine miliaria of areola
- Apocrine miliaria of axilla
- Apocrine miliaria of vulva
- Breast present
- Eruption of female perineum
- Eruption of vulva
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to L75.2: its own notes plus those printed at L75, block L60-L75, and Chapter 12. A note printed at a category, block or chapter applies to every code under it.
Applicable To
Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.
- Fox-Fordyce disease
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- congenital malformations of integument (Q84.-)
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- lipomelanotic reticulosis (I89.8)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- viral warts (B07.-)
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name L75.2, its category, or a range that includes it.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Disease, diseased See Also: Syndrome;
Fordyce-Fox disease L75.2
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Fox-Fordyce Disease
chronic pruritic disease, usually in women, characterized by small follicular papular eruptions in apocrine glands areas. it is caused by obstruction and rupture of intraepidermal apocrine ducts.
Patient EducationClinical
Rashes
A rash is an area of irritated or swollen skin. Many rashes are itchy, red, painful, and irritated. Some rashes can also lead to blisters or patches of raw skin. Rashes are a symptom of many different medical problems. Other causes include irritating substances and allergies. Certain genes can make people more likely to get rashes.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert L75.2 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About L75.2Overview
What is the ICD-10 code for apocrine miliaria?
The ICD-10-CM code for apocrine miliaria is L75.2 (sometimes written as L752). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is L75.2 (Apocrine sweat disorders) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report apocrine miliaria on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does L75.2 group to?
When apocrine miliaria is the principal diagnosis on an inpatient stay, it groups to MS-DRG 607, 606, with relative weights from 0.8772 to 1.5721 depending on complications. Higher weights mean higher Medicare reimbursement.
Can L75.2 be reported with L30.1?
Not as a rule. The Excludes1 note at L75, which applies to L75.2, lists "dyshidrosis (L30.1)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
What is the ICD-9 equivalent of L75.2?
Under the General Equivalence Mappings, apocrine miliaria converts to ICD-9-CM 705.82 (fox-fordyce disease). The mapping is a direct match.